Redsense Medical AB (publ) (NGM:REDS)
Sweden
· Delayed Price · Currency is SEK 6.00
+0.02 (0.33%)
At close: Jun 5, 2025
Redsense Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 31.92 | 28.77 | 25.52 | 16.75 | 16.34 | 17.1 | Upgrade
|
| Other Revenue | 0 | - | - | 0 | - | - | Upgrade
|
| Revenue | 31.92 | 28.77 | 25.52 | 16.75 | 16.34 | 17.1 | Upgrade
|
| Revenue Growth (YoY) | 57.58% | 12.74% | 52.32% | 2.51% | -4.43% | 20.19% | Upgrade
|
| Cost of Revenue | 12.62 | 10.69 | 12.36 | 5.49 | 5.95 | 7.14 | Upgrade
|
| Gross Profit | 19.3 | 18.08 | 13.16 | 11.27 | 10.4 | 9.96 | Upgrade
|
| Selling, General & Admin | 18.57 | 19.76 | 17.54 | 22.46 | 22.77 | 16.6 | Upgrade
|
| Other Operating Expenses | 0.95 | -1.96 | 0.59 | -1.04 | -0.56 | 1.25 | Upgrade
|
| Operating Expenses | 19.59 | 17.87 | 18.2 | 21.47 | 22.39 | 18.08 | Upgrade
|
| Operating Income | -0.29 | 0.21 | -5.04 | -10.21 | -11.99 | -8.12 | Upgrade
|
| Interest Expense | -0.04 | -0.04 | -0.03 | -0.1 | -0.05 | -0.04 | Upgrade
|
| Interest & Investment Income | 0.15 | 0.17 | 0.06 | 1.02 | 1.05 | 0.16 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -0.3 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 2.5 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | -0 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -0.17 | 0.34 | -5.01 | -6.79 | -11.29 | -8.01 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.5 | -1.97 | 3.32 | -1.03 | Upgrade
|
| Pretax Income | -0.17 | 0.34 | -4.51 | -8.76 | -7.97 | -9.03 | Upgrade
|
| Net Income | -0.17 | 0.34 | -4.51 | -8.76 | -7.97 | -9.03 | Upgrade
|
| Net Income to Common | -0.17 | 0.34 | -4.51 | -8.76 | -7.97 | -9.03 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 17 | 14 | 14 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 17 | 14 | 14 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | 25.74% | 21.25% | -0.16% | 0.60% | - | 15.33% | Upgrade
|
| EPS (Basic) | -0.01 | 0.02 | -0.32 | -0.62 | -0.57 | -0.64 | Upgrade
|
| EPS (Diluted) | -0.01 | 0.02 | -0.32 | -0.62 | -0.57 | -0.64 | Upgrade
|
| Free Cash Flow | -4.31 | -8.25 | -5.1 | -9.83 | -12.58 | -6.64 | Upgrade
|
| Free Cash Flow Per Share | -0.24 | -0.48 | -0.36 | -0.70 | -0.90 | -0.47 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | 2.140 | Upgrade
|
| Gross Margin | 60.46% | 62.83% | 51.56% | 67.24% | 63.63% | 58.22% | Upgrade
|
| Operating Margin | -0.91% | 0.73% | -19.74% | -60.93% | -73.37% | -47.50% | Upgrade
|
| Profit Margin | -0.53% | 1.19% | -17.69% | -52.27% | -48.78% | -52.83% | Upgrade
|
| Free Cash Flow Margin | -13.51% | -28.66% | -20.00% | -58.68% | -76.98% | -38.85% | Upgrade
|
| EBITDA | -0.22 | 0.28 | -4.98 | -10.16 | -11.97 | -8.09 | Upgrade
|
| EBITDA Margin | -0.70% | 0.96% | -19.50% | -60.61% | -73.21% | -47.33% | Upgrade
|
| D&A For EBITDA | 0.07 | 0.07 | 0.06 | 0.05 | 0.03 | 0.03 | Upgrade
|
| EBIT | -0.29 | 0.21 | -5.04 | -10.21 | -11.99 | -8.12 | Upgrade
|
| EBIT Margin | -0.91% | 0.73% | -19.74% | -60.93% | -73.37% | -47.50% | Upgrade
|
| Revenue as Reported | 34.82 | 32.63 | 25.56 | 17.79 | 16.9 | 17.15 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.